FK 506-based immunosuppression in clinical pancreas transplantation.
University of California, Davis Medical Center, Sacramento 95817, USA.
C
C
Swanson
M
M
Rubin
S
S
Colquhoun
G
G
Basadonna
A
A
Asshinnik
R
R
Perez
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000628:therapy; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D016035:Pancreas Transplantation / Q000009:adverse effects / Q000276:immunology / Q000379:methods*; D016559:Tacrolimus / Q000627:therapeutic use*
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine; D016559:Tacrolimus